Dr. Abbal Koirala, MD

Dr. Koirala practices at Fresenius Kidney Care Broadway Street in Potomac, Maryland.

Dr. Koirala's NPI, 1730449653, was assigned on May 24, 2012. Dr. Koirala holds Maryland license D0100321.

Dr. Koirala's primary practice is Fresenius Kidney Care Broadway Street, at 1201 7 Locks Rd, Potomac, MD 20854 in Montgomery County. The practice phone is (410) 261-3252.

Dr. Koirala's primary practice is Fresenius Kidney Care Broadway Street in Potomac, Maryland. Dr. Koirala is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Koirala to 1 more hospital and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koirala practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Koirala's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Koirala's licenses on file in 2 states: Maryland and Washington.

CMS data shows 528 Medicare services from Dr. Koirala across 10 procedure codes in 2024, for 309 Medicare patients. Medicare paid $53,096 for them.

CMS counts 309 Medicare patients who saw Dr. Koirala in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 39% are also on Medicaid. Their average risk score is 4.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Koirala's median patient age at 72, with 48% women.

In 2024, Dr. Koirala wrote 2,698 Medicare Part D claims for 228 patients. 76% of them were for generic drugs. CMS names the drug for 2,341 of them, across 57 drugs with 11 or more claims each, at $670,685 in total drug cost. In 2023, CMS named 2,935 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Koirala for performance year 2024, reported through an alternative payment model (APM). CMS lists Dr. Koirala as offering telehealth.

Dmand AI links 12 papers to Dr. Koirala, published from 2020 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Biopsy, Kidney and Kidney Glomerulus. Dr. Koirala has published most often in Adv Kidney Dis Health. Dr. Koirala's most frequent co-authors are Nayan Arora, MD, Shreeram Akilesh, MD, PhD and Mohamed G. Atta, MD.

CMS Open Payments shows 4 general payments to Dr. Koirala from 3 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 98% of the total. Calliditas Therapeutics US Inc. paid the most, $4,200.